Suppr超能文献

在开始抗逆转录病毒治疗之前,CD4 细胞迅速减少预示着尽管 HIV 病毒得到抑制,但随后仍会重建失败。

Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.

机构信息

Department of Internal Medicine, Jazan University, Saudi Arabia; Manitoba HIV Program, Canada; Department of Internal Medicine, University of Manitoba, Canada.

Department of Internal Medicine, University of Manitoba, Canada.

出版信息

J Infect Public Health. 2018 Mar-Apr;11(2):265-269. doi: 10.1016/j.jiph.2017.08.001. Epub 2017 Aug 18.

Abstract

HIV-1 infection is characterized by loss of CD4T cells, leading to immunodeficiency. Initiation of antiretroviral therapy (ART) results in suppression of the viral load and increased CD4 counts. Both viral and host factors determine CD4 cell responses to ART with approximately 15-30% of individuals having suboptimal increase of CD4T cell count, most commonly due to lack of compliance to ART. A smaller fraction of patients will have immune reconstitution failure and suboptimal CD4 increase despite suppression of HIV replication, and these individuals are at risk for adverse health outcomes. We sought to characterize the factors associated with decreased immunological response among Manitoba's HIV patient population. This retrospective case-control study included HIV patients with immune reconstitution failure despite suppression of HIV replication by ART. The immune reconstitution failure was defined by CD4 cell count increase from baseline of less than 100 CD4 cells/mm or lack of increase to above 200 CD4 cells/mm within one year of viral load suppression. Age and nadir CD4 cell counts are known risk factors associated with immune reconstitution failure. We chose controls (Patients with immune reconstitution success) of similar age and CD4 nadir cell with cases (Patients with immune reconstitution failure). We explored the potential effects of gender, HLA type, presence of co-infection, ethnicity, ART type, and rate of pre-treatment CD4 decline among cases and controls. Of more than 550 patients followed by our HIV clinic, 42 individuals met our definition of immune reconstitution failure and they were assigned to the cases group. 31 patients, comprising a range of ages and CD4 nadirs similar to those of the cases, were assigned to the control group. Our primary analysis was a regression model, predicting post-ART change in CD4 over time. After controlling for age and nadir CD4 cell counts, the only potential predictor that appears consistently associated with the rate of post-ART rise in CD4 over time in our cohort, regardless of the other variables that we have controlled for, is the rate of decline in CD4 pre-ART initiation. Several factors have been variably correlated with immune reconstitution failure of CD4 T cell count. Age and low CD4 nadir are factors previously shown to correlate with immune reconstitution failure; and we have controlled for them in our study. Another possible predictor is the rate of decline in CD4 pre-ART, which can serve as an additional marker of reconstitution failure and necessitate prioritizing individuals to ART initiation or identification of a subset of individuals that may be targeted for future adjunct strategies to improve immune recovery.

摘要

HIV-1 感染的特征是 CD4T 细胞的丧失,导致免疫功能缺陷。启动抗逆转录病毒治疗 (ART) 可抑制病毒载量并增加 CD4 计数。病毒和宿主因素共同决定了 CD4 细胞对 ART 的反应,大约 15-30%的个体 CD4T 细胞计数增加不理想,最常见的原因是缺乏对 ART 的依从性。一小部分患者尽管 HIV 复制受到抑制,但会出现免疫重建失败和 CD4 增加不理想,这些患者存在不良健康结局的风险。我们试图描述曼尼托巴省 HIV 患者人群中免疫反应下降的相关因素。这项回顾性病例对照研究纳入了尽管 ART 抑制了 HIV 复制但仍出现免疫重建失败的 HIV 患者。免疫重建失败的定义是 CD4 细胞计数从基线增加不足 100 个/立方毫米,或在病毒载量抑制后一年内未能增加到 200 个/立方毫米以上。年龄和 CD4 细胞计数最低点是与免疫重建失败相关的已知危险因素。我们选择了与病例具有相似年龄和 CD4 细胞计数最低点的对照组(免疫重建成功的患者)。我们探讨了性别、HLA 类型、合并感染、种族、ART 类型以及治疗前 CD4 下降率等因素在病例和对照组中的潜在影响。在我们的 HIV 诊所随访的 550 多名患者中,有 42 名符合免疫重建失败的定义,被分配到病例组。31 名患者,包括与病例相似的年龄和 CD4 细胞计数最低点范围,被分配到对照组。我们的主要分析是一个回归模型,预测 CD4 在 ART 后的时间变化。在控制年龄和 CD4 细胞计数最低点后,无论我们控制了哪些其他变量,与我们队列中 CD4 在 ART 后上升速度相关的唯一潜在预测因素是 ART 前 CD4 下降速度。有几个因素与 CD4 T 细胞计数的免疫重建失败呈不同程度的相关。年龄和低 CD4 细胞计数最低点是与免疫重建失败相关的已知因素;我们在研究中已经控制了这些因素。另一个可能的预测因素是 ART 前 CD4 的下降速度,它可以作为免疫重建失败的一个额外标志物,并需要优先考虑开始 ART 或确定可能需要未来辅助策略以改善免疫恢复的个体亚群。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验